Government ContextGovernment Context
TopicsAgenciesDocumentsPricingLog inCreate account
TopicsAgenciesDocumentsPricing
LoginCreate account
DetailsRelated

7-OH Mitragynine-related substances DEA-1644 HHS Letter to DEA

Supporting & Related MaterialDEA_FRDOC_0001-0534
Document

Details

The document's own metadata, straight from the source system.

Title
7-OH Mitragynine-related substances DEA-1644 HHS Letter to DEA
Posted
Jul 9, 2026
Agency
Drug Enforcement Administration (DEA)
Topics
  • Drug Enforcement and Control
  • Mental Health & Substance Abuse
View on regulations.gov ↗
Related

Related documents

Other documents filed with this rulemaking.

View related documents
Supporting & Related Material
DEA-1644 Three Factor Analysis for Temporary Control of Mitragynine pseudoindoxyl MGM-15 and MGM-16
No comment periodJul 9, 2026
NPRM
Designation of Phenethyl Halides as List I Chemicals
OpenJul 9, 2026
NPRM
Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
OpenJul 8, 2026
Proposed Rule
Schedules of Controlled Substances: Temporary Placement of 7-Hydroxymitragynine above a Specified Threshold in Schedule I
No comment periodJul 6, 2026
Proposed Rule
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
No comment periodJul 6, 2026

On this page

DetailsRelated
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ExploreDocumentsTopicsAgencies
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.